Envestnet Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $242M | Sell |
487,627
-15,937
| -3% | -$7.06M | 0.06% | 305 |
|
|
2026
Q1 | $225M | Buy |
503,564
+31,921
| +7% | +$14.9M | 0.06% | 292 |
|
|
2025
Q4 | $214M | Buy |
471,643
+888
| +0.2% | +$383K | 0.06% | 286 |
|
|
2025
Q3 | $184M | Buy |
470,755
+21,767
| +5% | +$9.1M | 0.05% | 338 |
|
|
2025
Q2 | $200M | Sell |
448,988
-21,340
| -5% | -$9.83M | 0.06% | 307 |
|
|
2025
Q1 | $228M | Buy |
470,328
+47,630
| +11% | +$22.2M | 0.07% | 262 |
|
|
2024
Q4 | $170M | Buy |
422,698
+19,630
| +5% | +$9.1M | 0.05% | 325 |
|
|
2024
Q3 | $187M | Sell |
403,068
-11,992
| -3% | -$5.76M | 0.06% | 293 |
|
|
2024
Q2 | $195M | Buy |
415,060
+11,751
| +3% | +$5.1M | 0.07% | 261 |
|
|
2024
Q1 | $169M | Sell |
403,309
-9,320
| -2% | -$3.94M | 0.06% | 290 |
|
|
2023
Q4 | $168M | Buy |
412,629
+1,143
| +0.3% | +$422K | 0.07% | 280 |
|
|
2023
Q3 | $143M | Buy |
411,486
+105,232
| +34% | +$36.8M | 0.07% | 286 |
|
|
2023
Q2 | $108M | Sell |
306,254
-1,145,620
| -79% | -$386M | 0.05% | 322 |
|
|
2023
Q1 | $92.7M | Buy |
1,451,874
+1,167,674
| +411% | +$350M | 0.04% | 346 |
|
|
2022
Q4 | $82.1M | Buy |
284,200
+14,768
| +5% | +$4.5M | 0.04% | 359 |
|
|
2022
Q3 | $78M | Buy |
269,432
+13,885
| +5% | +$3.99M | 0.04% | 339 |
|
|
2022
Q2 | $72M | Sell |
255,547
-52,192
| -17% | -$14M | 0.04% | 353 |
|
|
2022
Q1 | $80.3M | Buy |
307,739
+38,499
| +14% | +$9.14M | 0.04% | 357 |
|
|
2021
Q4 | $59.1M | Buy |
269,240
+20,854
| +8% | +$4.06M | 0.03% | 438 |
|
|
2021
Q3 | $45.1M | Buy |
248,386
+53,642
| +28% | +$10.5M | 0.02% | 489 |
|
|
2021
Q2 | $39.3M | Sell |
194,744
-13,933
| -7% | -$2.91M | 0.02% | 525 |
|
|
2021
Q1 | $44.8M | Buy |
208,677
+19,743
| +10% | +$4.34M | 0.03% | 440 |
|
|
2020
Q4 | $44.7M | Sell |
188,934
-108
| -0.1% | -$24.8K | 0.03% | 380 |
|
|
2020
Q3 | $51.4M | Buy |
189,042
+25,601
| +16% | +$7.06M | 0.05% | 298 |
|
|
2020
Q2 | $47.4M | Buy |
163,441
+49,186
| +43% | +$13.3M | 0.05% | 295 |
|
|
2020
Q1 | $27.2M | Buy |
114,255
+20,284
| +22% | +$4.65M | 0.03% | 367 |
|
|
2019
Q4 | $20.6M | Buy |
93,971
+6,621
| +8% | +$1.34M | 0.02% | 522 |
|
|
2019
Q3 | $14.8M | Buy |
87,350
+3,372
| +4% | +$597K | 0.02% | 585 |
|
|
2019
Q2 | $15.4M | Buy |
83,978
+3,297
| +4% | +$576K | 0.02% | 564 |
|
|
2019
Q1 | $14.8M | Buy |
80,681
+9,146
| +13% | +$1.69M | 0.02% | 542 |
|
|
2018
Q4 | $11.9M | Buy |
71,535
+58,803
| +462% | +$10.2M | 0.02% | 544 |
|
|
2018
Q3 | $2.45M | Sell |
12,732
-13,821
| -52% | -$2.46M | ﹤0.01% | 568 |
|
|
2018
Q2 | $4.51M | Buy |
26,553
+8,887
| +50% | +$1.38M | 0.01% | 524 |
|
|
2018
Q1 | $2.88M | Sell |
17,666
-15,954
| -47% | -$2.61M | 0.01% | 574 |
|
|
2017
Q4 | $5.04M | Buy |
33,620
+1,373
| +4% | +$203K | 0.01% | 594 |
|
|
2017
Q3 | $4.9M | Buy |
32,247
+8,088
| +33% | +$1.22M | 0.01% | 560 |
|
|
2017
Q2 | $3.11M | Buy |
24,159
+5,525
| +30% | +$665K | 0.01% | 754 |
|
|
2017
Q1 | $2.04M | Buy |
18,634
+3,597
| +24% | +$317K | 0.01% | 928 |
|
|
2016
Q4 | $1.11M | Sell |
15,037
-2,668
| -15% | -$217K | ﹤0.01% | 1143 |
|
|
2016
Q3 | $1.54M | Sell |
17,705
-9,276
| -34% | -$877K | 0.01% | 1053 |
|
|
2016
Q2 | $2.32M | Sell |
26,981
-2,069
| -7% | -$179K | 0.01% | 950 |
|
|
2016
Q1 | $2.31M | Sell |
29,050
-1,997
| -6% | -$181K | 0.01% | 915 |
|
|
2015
Q4 | $3.91M | Sell |
31,047
-3,653
| -11% | -$441K | 0.02% | 677 |
|
|
2015
Q3 | $3.61M | Buy |
34,700
+2,553
| +8% | +$328K | 0.02% | 697 |
|
|
2015
Q2 | $3.97M | Buy |
32,147
+1,895
| +6% | +$239K | 0.02% | 715 |
|
|
2015
Q1 | $3.57M | Buy |
30,252
+30,062
| +15,822% | +$3.6M | 0.02% | 712 |
|
|
2014
Q4 | $23K | Buy |
190
+12
| +7% | +$1.35K | ﹤0.01% | 1695 |
|
|
2014
Q3 | $20K | Buy |
178
+83
| +87% | +$7.9K | ﹤0.01% | 1889 |
|
|
2014
Q2 | $9K | Sell |
95
-61
| -39% | -$4.28K | ﹤0.01% | 2102 |
|
|
2014
Q1 | $11K | Sell |
156
-48
| -24% | -$3.8K | ﹤0.01% | 1854 |
|
|
2013
Q4 | $15K | Sell |
204
-400
| -66% | -$27.9K | ﹤0.01% | 1602 |
|
|
2013
Q3 | $46K | Buy |
604
+10
| +2% | +$796 | ﹤0.01% | 1221 |
|
|
2013
Q2 | $48K | Buy |
+594
| New | +$43.7K | ﹤0.01% | 1179 |
|
Other funds holding VRTX
Envestnet Asset Management's VRTX Position: Q2 2026 in Review
Envestnet Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q2 2026, selling an estimated $7.06M and leaving 487,627 shares worth $242M. The position accounts for 0.06% of the portfolio, ranked #305.
Envestnet Asset Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Envestnet Asset Management held 487,627 shares of Vertex Pharmaceuticals worth $242M as of Q2 2026.
- Envestnet Asset Management sold 15,937 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.06M.
- Vertex Pharmaceuticals made up 0.06% of Envestnet Asset Management's portfolio in Q2 2026, its #305 holding.
- Envestnet Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.